Question 1

What are the potential benefits of the GVAX vaccine for my AML?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any risks or side effects associated with this vaccine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment process look like for me if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia clinical trial (NCT00116467). Contact the study team or your healthcare provider for specific answers.

What this study is about